Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 13/20 | 0.67 |
| ▸ | BCHE | P06276 | 11/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | MITF | O75030 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29729955 | 0.93 | ACHE (0.76) | ACHEBCHEKDM4ENPC1MITF | |
| SCHEMBL1127587 | 0.93 | ACHE (0.76) | ACHEBCHEKDM4ENPC1MITF | |
| Bromide SCHEMBL1069897 | 0.91 | ACHE (0.79) | ACHEBCHEKDM4ENPC1MITF | |
| Hydrochloric Acid SCHEMBL1071121 | 0.91 | ACHE (0.73) | ACHEBCHEKDM4ENPC1MITF | |
| Hydrochloric Acid SCHEMBL29943765 | 0.91 | ACHE (0.73) | ACHEBCHEKDM4ENPC1MITF | |
| SCHEMBL20263107 | 0.89 | ACHE (0.67) | ACHEBCHEKDM4ENPC1MITF | |
| SCHEMBL20657095 | 0.89 | ACHE (0.67) | ACHEBCHEKDM4ENPC1MITF | |
| SCHEMBL27540774 | 0.88 | ACHE (0.65) | ACHEBCHEKDM4ENPC1MITF | |
| SCHEMBL9644491 | 0.86 | ACHE (0.63) | ACHEBCHEKDM4ENPC1MITF | |
| SCHEMBL7026594 | 0.84 | ACHE (0.56) | ACHEBCHEKDM4ENPC1MITF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2022-03-29 | — | — | US | claimed |
| US-20210147364-A1 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2021-05-20 | — | — | US | claimed |
| US-11926727-B2 | Epoxy resin composition | HUNTSMAN INTERNATIONAL LLC (US) | 2024-03-12 | — | — | US | disclosed |
| US-20220135766-A1 | Epoxy Resin Composition | HUNTSMAN INTERNATIONAL LLC | 2022-05-05 | — | — | US | disclosed |
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2022-03-29 | — | — | US | disclosed |
| EP-3310838-B1 | EPOXY RESIN COMPOSITION | HUNTSMAN ADV MAT LICENSING SWITZERLAND GMBH (CH) | 2021-08-18 | — | — | EP | disclosed |
| US-20210147364-A1 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2021-05-20 | — | — | US | disclosed |
| US-20180171101-A1 | Epoxy Resin Composition | HUNTSMAN INTERNATIONAL LLC | 2018-06-21 | — | — | US | disclosed |
| EP-3310838-A1 | EPOXY RESIN COMPOSITION | Huntsman Advanced Materials Licensing (Switzerland) GmbH (CH) | 2018-04-25 | — | — | EP | disclosed |
| WO-2016202608-A1 | EPOXY RESIN COMPOSITION | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2016-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | CBR1, POR, CAT | ACHE 941/4885BCHE 1349/4885KDM4E 3025/4885 |
| US-20210147364-A1 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | CBR1, POR, CAT | ACHE 1023/4885BCHE 1674/4885KDM4E 3242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.